Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials

Published:2014-09-28 Issue:12 Volume:59 Page:1666-1674
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Svarovskaia Evguenia S.¹,Dvory-Sobol Hadas¹,Parkin Neil²,Hebner Christy¹,Gontcharova Viktoria¹,Martin Ross¹,Ouyang Wen¹,Han Bin¹,Xu Simin¹,Ku Karin¹,Chiu Sophia¹,Gane Edward³,Jacobson Ira M.⁴,Nelson David R.⁵,Lawitz Eric⁶,Wyles David L.⁷,Bekele Neby¹,Brainard Diana¹,Symonds William T.¹,McHutchison John G.¹,Miller Michael D.¹,Mo Hongmei¹

Affiliation:

1. Gilead Sciences, Foster City

2. Data First Consulting Inc, Belmont, California

3. University of Auckland, Auckland City Hospital, New Zealand

4. Weill Cornell Medical College, New York, New York

5. University of Florida, Gainesville

6. Texas Liver Institute, San Antonio

7. Division of Infectious Diseases, University of California, San Diego

Funder

Gilead Sciences, Inc.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/59/12/1666/28039465/ciu697.pdf

Reference46 articles.

1. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Hanafiah;Hepatology,2013

2. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource;Smith;Hepatology,2014

3. Phylogeny and molecular evolution of the hepatitis C virus;Jackowiak;Infect Genet Evol,2013

4. Hepatitis C virus: standard-of-care treatment;Pawlotsky;Adv Pharmacol,2013

5. Review of direct-acting antiviral agents for the treatment of chronic hepatitis C;Shah;Expert Opin Investig Drugs,2013

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus subtype distribution and resistance-associated substitutions in high-risk population groups in Guangdong Province, China;Infection, Genetics and Evolution;2024-09

2. An Increase in the Prevalence of Clinically Relevant Resistance-Associated Substitutions in Four Direct-Acting Antiviral Regimens: A Study Using GenBank HCV Sequences;Pathogens;2024-08-09

3. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07

4. Genetic diversity of hepatitis C virus and the prevalence of resistance mutations to NS5A inhibitors in the Krasnoyarsk region;South of Russia: ecology, development;2024-04-07

5. Molecular testing in emerging infectious diseases;Diagnostic Molecular Pathology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3